摘要
目的探讨血清AFP、AFU、CA19-9联合检测在原发性肝癌诊断中的意义。方法随机选择2015年1月—2018年1月本院附属医院收治的原发性肝癌患者45例作为研究组,另选择同时间段45例肝硬化患者为观察组和健康体检者45例为对照组,均行血清AFP、AFU、CA19-9联合检测,并进行结果比较。结果研究组AFP、AFU、CA19-9高于观察组和对照组,差异有统计学意义(P<0.05);研究组AFP、AFU、CA19-9联合检测阳性率93.33%,高于观察组的55.56%和对照组的2.22%,差异有统计学意义(P<0.05)。结论血清AFP、AFU、CA19-9联合检测在原发性肝癌诊断中应用价值较高。
Objective To explore the significance of combined detection of serum AFP,AFU and CA19-9 in the diagnosis of primary liver cancer.Methods Forty-five patients with primary liver cancer who were admitted to the affiliated hospital of our school from January 2015 to January 2018 were randomly selected as the study group.The other 45 liver cirrhosis patients in the same period were selected as the observation group and 45 healthy people as the control group.The serum AFP,AFU,CA19-9 were all detected together and the results were compared.Results AFP,AFU,and CA19-9 in the study group were significantly higher than those in the observation group and the control group(P<0.05).The positive rate of combined detection of AFP,AFU,and CA19-9 in the study group(93.33%)was significantly higher than that in the observation group(55.56%)and that of the control group(2.22%)(P<0.05).Conclusion The combined detection of serum AFP,AFU and CA19-9 is of high value in the diagnosis of primary hepatic carcinoma.
作者
刘慧
简洁雯
LIU Hui;JIAN Jiewen(Department of Medical Laboratory,Xinyang Vocational and Technical College,Xinyang He’nan 464000,China)
出处
《中国卫生标准管理》
2018年第14期114-116,共3页
China Health Standard Management
关键词
血清检测
原发性肝癌
血清分离
检出率
阳性率
诊断价值
serum detection
primary liver cancer
serum separation
detection rate
positive rate
diagnostic value
